High Quality 98% Benfotiamine CAS 22457-89-2 Benfotiamine

• Customization: Available
• CAS No.: 22457-89-2
• Formula: C19h23n4o6PS
• Model NO.: HB-Benfotiamine
• EINECS: 245-013-4
• Packaging Material: Plastic
• Storage Method: Normal
• Shelf Life: 2 Years
• Nutrient Composition: Amino Acid
• Resource: Natural
• The content of active substances: ＞90%
• Product Name: Benfotiamine
• Appearance: White Powder
• Molecular Weight: 105.5
• Solubility: Water Soluble
• Storage Store: Cool Dry Place
• MOQ: 1kg
• Sample: Available
• Melting Point: 200 C
• Other Name: Biotamin
• Transport Package: Foil Bag
• Specification: 1 bag
• Trademark: Herben
• Origin: China
• Production Capacity: 5000kg/Month

Product Description

High Quality CAS 22457-89-2 Benfotiamine

 

Product Description

Product Name: Benfotiamine
CAS No: 22457-89-2
EINECS No: 245-013-4
Molecular Formular: C19H23N4O6PS
Molecular Weight: 466.4479
Appearance: White crystalline powder
Solubility: insoluble in water

Benfotiamine is vitamin B1 fat soluble derivatives, improve the bioavailability of water-soluble vitamin B1 low shortcomings,improve the blood and tissue concentrations of thiamine, so as to improve the curative effect.Benfotiamine is primarily marketed as an antioxidant dietary supplement. In a clinical study with six patients, benfotiamine lowered AGE by 40%.

1.It is used for the prevention and treatment of vitamin B1 deficiency; 

2. For vitamin B1 demand increase, with inadequate intake from foods supplies (fatigue, hyperthyroidism, pregnancy, lactation, during strenuous manual labor, etc.);

3. Is used in the treatment of non alcoholic wernicke encephalopathy;

4. To treat beriberi; 

5. Used in the following diseases, speculation and vitamin B1 deficiency and metabolic disorders associated with treatment, such as: neuralgia; Muscle pain, joint pain; Peripheral neuritis, peripheral nerve palsy; Myocardial metabolic disorders; Constipation and other gastrointestinal motor function obstacle.

 

1. Benfotiamine is used for the prevention and treatment of vitamin B1 deficiency;
2. For vitamin B1 demand increase, with inadequate intake from foods supplies (fatigue, hyperthyroidism, pregnancy, lactation,
during strenuous manual labor, etc.);
3. Benfotiamine is used in the treatment of non alcoholic wernicke encephalopathy;
4. To treat beriberi;

Test Item	Analysis Specification	Result
Description	White to almost white crystal	White to almost white crystal
Identification	A: IR spectra shows the similarity between sample and standard B: The retention time of the major peak corresponds with it of the reference standard	Complies Complies
Solution color and clearness	Colorless to pale-yellow clear solution	Complies
Chlorides	Not more than 0.053%	<0.053%
Sulphate	Not more than 0.011%	<0.011%
Loss on drying	Not more than 1.5%	0.66%
Heavy metals	Not more than 0.002%	<0.002%
Related Substances	TMP :Not more than 0.15% Benzoic acid :not more than0.1% Amide: not more than 0.40% Single unknown impurity: not more than0.1% Thiamine: not more than0.1% Total impurities: Not more than 1.5%	<0.025% No detectable 0.06% 0.08% No detectable 0.33%
Residual solvents	Dichloromethane: not more than 600ppm Isopropanol: not more than300ppm	No detectable 64ppm
Microbial limits	Total bacteria: not more than100cfu/g Yeast and mould: not more than50cfu/g Escherichia coli: no detectable	<10 cfu/g <10 cfu/g No detectable
Assay(Dry Basis)	98.0%~102.0%	99.6%
Conclusion	Complies with company Standard.

 

 

 

 

Company Profile